EUVIMEDEUVIMED entdecken
Crossref

Retrospective Analysis of Incidence and Etiology of Severe Infections in Children Receiving Therapy for High‐Risk Neuroblastoma: A Large Single‐Center Experience

Elio Castagnola iD, Shana Montalto iD, Marcello Mariani iD, Massimo Conte, Stefania Sorrentino iD, Alessio Mesini, Erica Ricci iD, Carolina Saffioti iD, Roberto Bandettini, Emanuela Caci, Francesca Bagnasco iD, Carlo Dufour iD und 1 weitere

Pediatric Blood & Cancer · 2026-05 · 73 (5)

DOI: 10.1002/1545-5017.70203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 15.03.2026. Verfasst von Elio Castagnola und 12 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy. Hauptthemen laut MEDLINE: Neuroblastoma, Antineoplastic Combined Chemotherapy Protocols, Invasive Fungal Infections. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Italian Ministry of Health (Ricerca Corrente).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe infections are a leading cause of morbidity and mortality in pediatric oncology, especially among children receiving high‐dose chemotherapy. High‐risk neuroblastoma (HR‐NB) provides a paradigmatic model of prolonged multimodal treatment, yet recent data describing the burden and timing of severe infections during its therapeutic course are limited. Procedure We retrospectively reviewed 184 consecutive HR‐NB patients diagnosed and treated at the IRCCS Istituto Giannina Gaslini (Genoa, Italy) according to the SIOPEN/HR‐NBL1 protocol between 2002 and 2021. Severe infectious events were defined as bloodstream infections (BSI) and invasive fungal diseases (IFDs) according to international criteria. Incidence rates per 100 patient‐days at risk (pdr) and phase‐specific distributions (induction, consolidation, maintenance) were analyzed.

Results

Over 80,202 patient‐days at risk, 104 severe infections were recorded (cumulative incidence 56.5%). BSI represented 93.3% of events, predominantly Gram‐positive (55.8%) and Gram‐negative (37.5%) pathogens; 6.7% were IFDs. The induction phase accounted for the highest incidence, while consolidation (hematopoietic stem cell transplantation) showed the highest infection rate per pdr. Approximately 70% of BSI occurred in non‐neutropenic patients and were central venous catheter (CVC) related; in neutropenic cases (30%), half were CVC associated. Infection‐related mortality was 1.1% (two out of 184).

Conclusions

Severe infections remain frequent and clinically significant complications in HR‐NB therapy, though infection‐related mortality was low. The low incidence of IFDs despite the absence of systematic prophylaxis suggests potential optimization of preventive strategies. These data provide an epidemiologic benchmark for infection risk in the era of immunotherapy and CAR‐T approaches for solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaAntineoplastic Combined Chemotherapy ProtocolsInvasive Fungal InfectionsHumansFemaleMaleIncidenceRetrospective StudiesChild, PreschoolInfantChildAdolescentPrognosisFollow-Up StudiesRisk Factors

Stichwörter der Autor:innen

bloodstream infectioncentral venous catheterhigh‐risk neuroblastomainvasive fungal diseaseneutropeniapediatric oncology

Autor:innen und Institutionen

  • Infectious Diseases Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Hospital-at-home Care Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Hematology/Oncology Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Laboratory of Clinical Analysis, IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Epidemiology and Biostatistics Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy.

ORCID-Profile: Elio Castagnola, Shana Montalto, Marcello Mariani, Stefania Sorrentino, Erica Ricci, Carolina Saffioti, Francesca Bagnasco, Carlo Dufour

Förderung

  • Italian Ministry of Health (Ricerca Corrente)

Zitieren

APA

Castagnola, E., Montalto, S., Mariani, M., Conte, M., Sorrentino, S., Mesini, A., Ricci, E., Saffioti, C., Bandettini, R., Caci, E., Bagnasco, F., Dufour, C., & Garaventa, A. (2026). Retrospective Analysis of Incidence and Etiology of Severe Infections in Children Receiving Therapy for High‐Risk Neuroblastoma: A Large Single‐Center Experience. Pediatric Blood & Cancer, 73(5). https://doi.org/10.1002/1545-5017.70203

Vancouver

Castagnola E, Montalto S, Mariani M, Conte M, Sorrentino S, Mesini A, et al. Retrospective Analysis of Incidence and Etiology of Severe Infections in Children Receiving Therapy for High‐Risk Neuroblastoma: A Large Single‐Center Experience. Pediatric Blood & Cancer. 2026;73(5). doi:10.1002/1545-5017.70203

BibTeX
@article{Castagnola2026,
  author = {Castagnola, Elio and Montalto, Shana and Mariani, Marcello and Conte, Massimo and Sorrentino, Stefania and Mesini, Alessio and Ricci, Erica and Saffioti, Carolina and Bandettini, Roberto and Caci, Emanuela and Bagnasco, Francesca and Dufour, Carlo and Garaventa, Alberto},
  title = {Retrospective Analysis of Incidence and Etiology of Severe Infections in Children Receiving Therapy for High‐Risk Neuroblastoma: A Large Single‐Center Experience},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  volume = {73},
  number = {5},
  doi = {10.1002/1545-5017.70203}
}
Kostenlos starten →